Showing results (1-10 of 38) with videos related to
Sort By:
Pageof 4
Deutsche Medizinische Wochenschrift (1946)|September 11, 2018
[Individualized Treatment of Chronic Lymphocytic Leukemia (CLL)]Julia von Tresckow, Michael Hallek, Barbara EichhorstDeutsche Medizinische Wochenschrift (1946)|August 14, 2020
[Current diagnosis and treatment of chronic lymphocytic leukaemia]Paula Cramer, Julia von Tresckow, Barbara Eichhorst, et al.Deutsches Arzteblatt International|March 12, 2019
The Treatment of Chronic Lymphatic LeukemiaJulia von Tresckow, Barbara Eichhorst, Jasmin Bahlo, et al.Journal of Patient-Reported Outcomes|April 29, 2025
Development of a modular patient-reported outcome and experience measure on patient needs and benefits in CLL (PBI-CLL)Beke Hester, Julia Von Tresckow, Minna Voigtländer, et al.Radiology Case Reports|August 31, 2021
Thymic hyperplasia after mRNA based Covid-19 vaccinationJulia von Tresckow, Bastian von Tresckow, H Christian Reinhardt, et al.Leukemia & Lymphoma|June 10, 2025
Insights into the pathogenesis and biology of chronic lymphocytic leukemia through analysis of its B-cell receptorMaria Dampmann, Bastian von Tresckow, Hans Christian Reinhardt, et al.Leukemia & Lymphoma|December 17, 2024
Single-cell analysis of a bi-clonal chronic lymphocytic leukemia reveals two clones with distinct gene expression patternMaria Dampmann, Artur Kibler, Julia von Tresckow, et al.European Journal of Haematology|June 10, 2024
Time-dependent cost comparison and health economic impact analysis of second-line interventions for transplant-ineligible patients with relapsed or refractory diffuse large B cell lymphomaMelina Sophie Kurte, Ann-Cathrine Siefen, Florian Jakobs, et al.European Journal of Haematology|June 25, 2022
Early report on the severity of COVID-19 in hematologic patients infected with the SARS-CoV2 omicron variantFabian Ullrich, Christine Hanoun, Amin T Turki, et al.Future Oncology (London, England)|February 22, 2018
CLL2-BXX Phase II trials: sequential, targeted treatment for eradication of minimal residual disease in chronic lymphocytic leukemiaPaula Cramer, Julia von Tresckow, Jasmin Bahlo, et al.Pageof 4